VYOME HOLDINGS, INC. Increase (Decrease) in Due to Related Parties
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Due to Related Parties of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2018-03-05
- VYOME HOLDINGS, INC. increase (decrease) in due to related parties for the quarter ending 2015-12-31 was $0.00.
- VYOME HOLDINGS, INC. increase (decrease) in due to related parties for fiscal 2017 was $0.00.
- VYOME HOLDINGS, INC. increase (decrease) in due to related parties for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- VYOME HOLDINGS, INC. increase (decrease) in due to related parties for fiscal 2015 was $1.28M.
- VYOME HOLDINGS, INC. increase (decrease) in due to related parties for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-05 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $1.28M 10-K · filed 2018-03-05 | |
| 2015-09-30 | $1.28M 10-Q · filed 2016-11-10 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |